- QMRO Home
- Blizard Institute
- Centre for Immunobiology
- Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and-3 Clinical Trials
Browse
Administrators only